Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
International Journal of Medicinal Mushrooms
Impact-faktor: 1.423 5-jähriger Impact-Faktor: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Druckformat: 1521-9437
ISSN Online: 1940-4344

Volumes:
Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2019030047
pages 105-119

Cancer without Pharmacological Illusions and a Niche for Mycotherapy (Review)

Ivan V. Zmitrovich
Laboratory of Systematics and Geography of the Fungi of the Komarov Botanical Institute of the Russian Academy of Sciences, Prof. Popova St. 2, St. Petersburg, 197376, Russia
Nina V. Belova
Laboratory of Biochemistry of the Fungi of the Komarov Botanical Institute of the Russian Academy of Sciences, St. Petersburg, Russia
Mikhail E. Balandaykin
Department of Biology, Ulyanovsk State University, 42 L. Tolstoy St., Ulyanovsk 432017, Russia
Margarita A. Bondartseva
Laboratory of Systematics and Geography of Fungi, Komarov Botanical Institute of the Russian Academy of Sciences, Saint Petersburg, Russia
Solomon P. Wasser
N.G. Kholodny Institute of Botany, NAS of Ukraine, 2 Tereshchenkovskaya Str., Kiev 01004, Ukraine; International Center for Cryptogamic Plants and Fungi, Institute of Evolution, University of Haifa, Mount Carmel, Haifa, Israel

ABSTRAKT

In this review we outline a framework in which mycotherapy is effective in the field of oncology. We suppose that irreversible epigenomic changes in cancer cells and achieving their replicative immortality when cancer-specific targets are absent should take away any illusions about a fundamental possibility of pharmacological blockage of the cancer process once ontogenesis begins. At the same time, however, we believe that effects of both traditional and alternative medicines on cancer clonogenic units within a particular range can lead to prolonged remission; with this in mind, we carefully consider the various possibilities of mycotherapy in controlling cancer activity. The aforementioned range is limited to nondisseminated cancer processes and depends on the absence of large secondary tumor nodes and the inexhaustibility of immune depots after chemotherapeutic treatment. The main therapeutic effect of fungal bioactive complexes is dectin-1-mediated immunity, including the reprogramming of dendritic cells, which significantly increases the period during which tumors generate immune tolerance. An inhibitory effect of fungal bioactive complexes on some molecular mediators of proliferative signaling and components of proinflammatory (synergistic with cancer) immunity can be considered less significant. The effect of fungal bioactive complexes on vital (including overexpressed) targets of cancer cells is even more limited. The results of this study stress that mycotherapy is only one of the tools that can be used to balance remission. Palliative mycotherapy is associated with polyphenols composites, which contribute to detoxification and to the suppression of inflammation and pain sensation.


Articles with similar content:

Human Defensins and Cathelicidins in the Skin: Beyond Direct Antimicrobial Properties
Critical Reviews™ in Immunology, Vol.26, 2006, issue 6
Hideoki Ogawa, Isao Nagaoka, Francois Niyonsaba
Circadian Rhythms and Cancer Chemotherapy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.6, 1996, issue 4
Patricia A. Wood, William J. M. Hrushesky
Autophagy in tumor suppression and cancer therapy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.21, 2011, issue 1
Marika K. Bergenstock, Anna Budina, Maureen Murphy, Gregor Balaburski, Che-Pei Kung
Immune Privilege in the Anterior Chamber of the Eye
Critical Reviews™ in Immunology, Vol.22, 2002, issue 1
Jerry Y. Niederkorn
Induction of Cytokines and Chemokines by Toll-like Receptor Signaling: Strategies for Control of Infammation
Critical Reviews™ in Immunology, Vol.30, 2010, issue 1
Goutam Gupta, Ahmet Zeytun, Anu Chaudhary, Paige Pardington, R. Bruce Cary